Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Apr 14, 2022New health plan partnership improves access to digital health for historically underserved populations NEW YORK, April 14, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the...
- Mar 23, 2022Dario continues rapid expansion of employer business across multi-condition suite of solutions
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today two new employer agreements: first, with a U.S. based social platform employer and...
- Mar 22, 2022Transformational year delivered strong revenue growth of 190% quarter-over-quarter and 171% full year-over-full year
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today reported financial results for the fourth quarter and full year 2021 and provided a corporate and...
- Mar 14, 2022Company to host conference call and webcast on Tuesday, March 22, at 8:30 am ET
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the fourth quarter and full year ended...
- Mar 9, 2022New clients continue Dario's track record of success in winning employer and provider business
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today new agreements with a regional employer and a regional provider. The contracts are...
- Mar 7, 2022
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced that management will participate in the Cowen 42nd Annual Healthcare Conference, which...
-
Mar 1, 2022Novel Strategic Agreement Focuses on Commercial Growth for Dario and the Development of Digital Health Solutions on Dario's Platform
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced it has entered into a strategic agreement with Sanofi U.S., an innovative global healthcare...
- Mar 1, 2022
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that on February 28, 2022 it entered into definitive agreements with institutional...
- Feb 9, 2022New peer-reviewed study sheds light on the effectiveness of an integrated approach for Dario users with both diabetes and high blood pressure.
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced the publication of a retrospective, real-world study demonstrating the impact of managing...
- Feb 8, 2022New contracts expand Dario's footprint to more than 40 clients in the employer market
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced several new contracts to deliver its digital therapeutics solutions for four new...